Junshi Biosciences Announces Lancet Infectious Diseases

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Related Keywords

Zhejiang ,China ,Xinjiang ,Jiangxi ,Maryland ,United States ,Shanghai ,Beijing ,Guangzhou ,Guangdong ,Lihua ,Jilin ,Suzhou ,Jiangsu ,Jianjun ,Shaanxi ,Uzbekistan ,Wuhan ,Hubei ,Yun Ling ,Anhui ,Xiahong ,Lingang ,California ,Chinese ,Zhi Li ,Junshi Biosciences ,Xinjiang Technical Institute Of Physics ,Wuhan Institute Of Virology ,Central Asian Center ,Shanghai Junshi Biosciences Co Ltd ,Shanghai Public Health Clinical Center ,Global Research ,Shanghai Institute Of Materia Medica ,Development Chinese Academy Of Sciences China ,Ir Team ,Vigonvita Life Sciences Co Ltd ,Pr Team ,Lingang Laboratory ,Chinese Academy Of Sciences ,Lancet Infectious ,State Key Laboratory ,Infectious Diseases ,Zhejiang University ,Hospital Affiliated ,New England Journal ,Development President ,Mindeudesivir Hydrobromide Tablets ,Shanghai Institute ,Materia Medica ,Chinese Academy ,Wuhan Institute ,Xinjiang Technical Institute ,Drug Discovery ,Development Chinese Academy ,China Uzbekistan Medicine Technical Park ,Joint Laboratory ,For Global ,Hong Kong Stock Exchange 1877 Hk ,